DeepX Health is pleased to announce that the DermoSight Teledermatology Solution is now in use in a primary care setting, as a new pilot has been setup in a collaboration between DeepX Health Ltd and the NHS. The DermoSight platform was initiated in an existing NHS Primary Care teledermatology service following disruption and delays due to COVID-19. Within the first month of implementation benefits were realised when compared to the current system with regards to:

-      Ease of use and efficiency with administrative time saved

-      Consistent quality of images and no rejected consultations

-      Improvements in the recording, reporting and advice received

A decision to expand the service to other high output sites was made and implemented after the first 3-month trial.

‍